# FDA Inspection 784588 - Vitalant - May 18, 2012

Source: https://www.keypedia.com/records/fda_inspections/vitalant/325a8181-e288-46b9-8a77-f05483cbcb4d
Source feed: FDA_Inspections

> FDA Inspection 784588 for Vitalant on May 18, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 784588
- Company Name: Vitalant
- Inspection Date: 2012-05-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1281750 - 2025-08-29](https://www.keypedia.com/records/fda_inspections/vitalant/4828ff80-6984-40e3-99a4-0ad4117b9f84)
- [FDA Inspection 1281750 - 2025-08-29](https://www.keypedia.com/records/fda_inspections/vitalant/ae29ad84-6e79-4024-92d2-f7c31489fdac)
- [FDA Inspection 1167691 - 2022-04-12](https://www.keypedia.com/records/fda_inspections/vitalant/0dec7246-f406-4278-9785-d31a3aaa8b02)
- [FDA Inspection 1167691 - 2022-04-12](https://www.keypedia.com/records/fda_inspections/vitalant/74a42180-2e05-4740-ad33-77c4778528dd)
- [FDA Inspection 1037711 - 2017-12-07](https://www.keypedia.com/records/fda_inspections/vitalant/e5858cea-4756-40ce-a86f-7966ad078532)

Company: https://www.keypedia.com/companies/vitalant/f05cb944-4412-45b4-9314-3b7733e6379b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d